Drug intelligence / Profile preview

MKK-H10

Development stage
Preclinical
Lead developer
MAXVAX Biotechnology
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

MKK-H10 is a recombinant 10-valent human papillomavirus (HPV) vaccine candidate currently in preclinical development by MAXVAX Biotechnology. The vaccine is designed to provide broad-spectrum protection against ten different genotypes of HPV, including high-risk types associated with cervical, anal, and oropharyngeal cancers, as well as low-risk types that cause genital warts. It utilizes recombinant protein technology to produce virus-like particles (VLPs) that mimic the viral structure to induce a robust neutralizing antibody response without containing actual viral DNA. MKK-H10 aims to expand upon the coverage provided by existing 9-valent vaccines by targeting additional high-risk genotypes prevalent in specific populations.

Other names
Recombinant 10-valent HPV vaccineRecombinant10-valent HPV vaccineRecombinant-10-valent HPV vaccine10-valent human papillomavirus vaccine

Beyond the preview

Go deeper on MKK-H10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MKK-H10.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call